Trial Outcomes & Findings for Technology Intensified Diabetes Education Study in African Americans (NCT NCT02088658)
NCT ID: NCT02088658
Last Updated: 2026-03-06
Results Overview
Hemoglobin A1c (HbA1c): blood specimens collected at the 12-months follow-up visit
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
200 participants
Primary outcome timeframe
12 months post randomization
Results posted on
2026-03-06
Participant Flow
Participant milestones
| Measure |
Techonology Intensified
Subjects randomized to this group will receive: 1) the FORA system for self-monitoring; 2) weekly telephone-delivered diabetes education/skills training; 3) patient activation (list of 5 questions to ask their provider at every visit and training on how to ask the questions); and 4) patient empowerment (diabetes responsibility contracts, personal goals, and flow charts for patients to record lab results/medications and training on how to use the empowerment tools). The intervention will be delivered by telephone once a week for 12 weeks with each session lasting \~30 minutes.
Technology Intensified: The intervention is based on the Information-Motivation-Behavioral Skills (IMB) model and provides information, motivation, and behavioral skills training (using motivational enhancement techniques). Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse educators will have access to a secure server to which the uploaded measurements are stored in real time. The glucose and BP readings will be used to tailor and reinforce behavior change during weekly telephone-delivered diabetes education sessions.
|
Usual Care
Apart from study visits, patients will be followed by their primary care providers. The provider will be responsible for determining treatment parameters, making changes in the treatment regimen, and determining the timing of follow up visits. Between scheduled office encounters, contact between patient and provider will be patient initiated. The provider may use clinic nurses to follow up on problematic patients or patients with abnormal results. In essence, this group will receive the current standard of care at the study clinics.
|
|---|---|---|
|
Overall Study
STARTED
|
95
|
105
|
|
Overall Study
COMPLETED
|
85
|
94
|
|
Overall Study
NOT COMPLETED
|
10
|
11
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Technology Intensified Diabetes Education Study in African Americans
Baseline characteristics by cohort
| Measure |
Usual Care
n=105 Participants
Apart from study visits, patients will be followed by their primary care providers. The provider will be responsible for determining treatment parameters, making changes in the treatment regimen, and determining the timing of follow up visits. Between scheduled office encounters, contact between patient and provider will be patient initiated. The provider may use clinic nurses to follow up on problematic patients or patients with abnormal results. In essence, this group will receive the current standard of care at the study clinics.
|
Total
n=200 Participants
Total of all reporting groups
|
Techonology Intensified
n=95 Participants
Subjects randomized to this group will receive: 1) the FORA system for self-monitoring; 2) weekly telephone-delivered diabetes education/skills training; 3) patient activation (list of 5 questions to ask their provider at every visit and training on how to ask the questions); and 4) patient empowerment (diabetes responsibility contracts, personal goals, and flow charts for patients to record lab results/medications and training on how to use the empowerment tools). The intervention will be delivered by telephone once a week for 12 weeks with each session lasting \~30 minutes.
Technology Intensified: The intervention is based on the Information-Motivation-Behavioral Skills (IMB) model and provides information, motivation, and behavioral skills training (using motivational enhancement techniques). Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse educators will have access to a secure server to which the uploaded measurements are stored in real time. The glucose and BP readings will be used to tailor and reinforce behavior change during weekly telephone-delivered diabetes education sessions.
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=35 Participants
|
0 Participants
n=76 Participants
|
0 Participants
n=41 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
89 Participants
n=35 Participants
|
177 Participants
n=76 Participants
|
88 Participants
n=41 Participants
|
|
Age, Categorical
>=65 years
|
16 Participants
n=35 Participants
|
23 Participants
n=76 Participants
|
7 Participants
n=41 Participants
|
|
Age, Continuous
|
56.8 years
STANDARD_DEVIATION 12.7 • n=35 Participants
|
56.2 years
STANDARD_DEVIATION 11.8 • n=76 Participants
|
55.6 years
STANDARD_DEVIATION 10.8 • n=41 Participants
|
|
Sex: Female, Male
Female
|
73 Participants
n=35 Participants
|
133 Participants
n=76 Participants
|
60 Participants
n=41 Participants
|
|
Sex: Female, Male
Male
|
32 Participants
n=35 Participants
|
67 Participants
n=76 Participants
|
35 Participants
n=41 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic Black
|
105 Participants
n=35 Participants
|
200 Participants
n=76 Participants
|
95 Participants
n=41 Participants
|
|
Region of Enrollment
United States
|
105 Participants
n=35 Participants
|
200 Participants
n=76 Participants
|
95 Participants
n=41 Participants
|
|
Hemoglobin A1c
|
10.3 mean percentage of HbA1c
STANDARD_DEVIATION 1.8 • n=35 Participants
|
10.3 mean percentage of HbA1c
STANDARD_DEVIATION 1.8 • n=76 Participants
|
10.4 mean percentage of HbA1c
STANDARD_DEVIATION 1.8 • n=41 Participants
|
PRIMARY outcome
Timeframe: 12 months post randomizationHemoglobin A1c (HbA1c): blood specimens collected at the 12-months follow-up visit
Outcome measures
| Measure |
Techonology Intensified
n=95 Participants
Subjects randomized to this group will receive: 1) the FORA system for self-monitoring; 2) weekly telephone-delivered diabetes education/skills training; 3) patient activation (list of 5 questions to ask their provider at every visit and training on how to ask the questions); and 4) patient empowerment (diabetes responsibility contracts, personal goals, and flow charts for patients to record lab results/medications and training on how to use the empowerment tools). The intervention will be delivered by telephone once a week for 12 weeks with each session lasting \~30 minutes.
Technology Intensified: The intervention is based on the Information-Motivation-Behavioral Skills (IMB) model and provides information, motivation, and behavioral skills training (using motivational enhancement techniques). Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse educators will have access to a secure server to which the uploaded measurements are stored in real time. The glucose and BP readings will be used to tailor and reinforce behavior change during weekly telephone-delivered diabetes education sessions.
|
Usual Care
n=105 Participants
Apart from study visits, patients will be followed by their primary care providers. The provider will be responsible for determining treatment parameters, making changes in the treatment regimen, and determining the timing of follow up visits. Between scheduled office encounters, contact between patient and provider will be patient initiated. The provider may use clinic nurses to follow up on problematic patients or patients with abnormal results. In essence, this group will receive the current standard of care at the study clinics.
|
|---|---|---|
|
Hemoglobin A1c
|
9.8 mean percent of HbA1c
Standard Deviation 2.1
|
9.6 mean percent of HbA1c
Standard Deviation 1.7
|
Adverse Events
Techonology Intensified
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Usual Care
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place